dynamic in vitro systems | CMAC

dynamic in vitro systems

Antimutant activity of the combination of colistin and rifaximin in selective digestive decontamination: validation in a dynamic flow-through system

Objective. Introduction. Selective digestive decontamination of the digestive tract (SDD) with non-absorbable antibiotics is considered a promising approach to reduce the risk of infections in critically ill patients. However, the widespread circulation of multidrug-resistant microorganisms, including carbapenemresistant Klebsiella pneumoniae and Pseudomonas aeruginosa, significantly reduces the efficacy of conventional SDD regimens based on colistin monotherapy. The key reason for failures is the wide «mutant selection window» – a range of antibiotic concentrations insufficient to suppress the growth of resistant subpopulations.